Neuphoria Therapeutics Inc. - NEUP
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 06, 2026 | SCHEDULE 13G/A | Baselake Partners, LP | 4.1% | 222,222 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Baselake Management, LLC | 4.1% | 222,222 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | David Paolella | 4.1% | 222,222 | View |
| Dec 29, 2025 | SCHEDULE 13D/A | — | — | 5,377,329 | View |
| Dec 02, 2025 | SCHEDULE 13D/A | — | — | 5,377,329 | View |
| Nov 28, 2025 | SCHEDULE 13D/A | — | — | 5,377,329 | View |
| Nov 18, 2025 | SCHEDULE 13D/A | — | — | — | View |
| Nov 10, 2025 | SCHEDULE 13D/A | — | 27.0% | 3,298,042 | View |
| Nov 05, 2025 | SCHEDULE 13G | Coastlands Capital LP | 5.1% | 120,000 | View |
| Nov 05, 2025 | SCHEDULE 13G | Coastlands Capital Partners LP | 5.1% | 120,000 | View |
| Nov 05, 2025 | SCHEDULE 13G | Coastlands Capital GP LLC | 5.1% | 120,000 | View |
| Nov 05, 2025 | SCHEDULE 13G | Coastlands Capital LLC | 5.1% | 120,000 | View |
| Nov 05, 2025 | SCHEDULE 13G | Matthew D. Perry | 5.1% | 120,000 | View |
| Oct 31, 2025 | SCHEDULE 13G | Baselake Partners, LP | 9.4% | 222,222 | View |
| Oct 31, 2025 | SCHEDULE 13G | Baselake Management, LLC | 9.4% | 222,222 | View |
| Oct 31, 2025 | SCHEDULE 13G | David Paolella | 9.4% | 222,222 | View |
| Oct 31, 2025 | SCHEDULE 13G | Shay Capital LLC | 7.3% | 171,629 | View |
| Oct 31, 2025 | SCHEDULE 13G | Shay Capital Holdings LLC | 7.3% | 171,629 | View |
| Oct 23, 2025 | SCHEDULE 13D | — | — | 2,357,613 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.